Ads
related to: biotechnology biotechdirexion.com has been visited by 100K+ users in the past month
- Bull & Bear 3X ETFs
Fixed Income, International Equity
Market Cap And Sector Equity
- Pharma ETF
Direxion Pharma & Medical ETF
Daily Bull 3X Shares - PILL
- Healthcare ETF
Direxion Daily Healthcare ETF
Bull 3X Shares ETF - CURE
- ETF Line-up
View Direxion's Complete List of
Leveraged and Inverse ETFs.
- Education
Articles, videos & tools to help
understand Leveraged ETFs and more.
- ETF Education
View Our Educational Library to
Learn More About Our Products.
- Bull & Bear 3X ETFs
Search results
Activation Capital Introduces 'Frontier BioHealth' to Catalyze Life Science Startups
FOX 59 Indianapolis· 2 hours agoEmerging pharmaceutical, biotechnology, medical device, and health-focused consumer products...
Krystal Biotech (KRYS) Gains 36% Year to Date: Here's Why
Zacks via Yahoo Finance· 6 hours agoShares of the commercial-stage biotechnology company, Krystal Biotech, Inc. KRYS, surged 36.5% year...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance· 4 hours agoMergers and acquisitions continue to be in the spotlight as pharma and biotech majors look to...
Durham biotech, Eli Lilly ink billion-dollar deal aimed at cancer treatments - Triangle Business...
The Business Journals· 9 hours agoA biotechnology firm with operations in Durham is working on a major deal with with Eli Lilly and...
Biotech Bootcamp: Equipping the Future Workforce in the Life Sciences Industry
PRWeb· 8 hours agoThe Biotech Bootcamp consists of a four-week program offered both in the morning and evening, four...
Krystal Biotech director sells over $3.2 million in company stock By Investing.com
Investing.com· 23 hours agoIn a recent transaction, Julian S. Gangolli, a director at Krystal Biotech , Inc. (NASDAQ:KRYS),...
An Emerging Hub: How Biotech Spread to Allston | News | The Harvard Crimson
The Harvard Crimson· 14 hours agoIncendia, along with nearly a dozen other biotech companies, have moved into the neighborhood over the last decade. “We’re leaving, because we’re not happy,” Incendia CEO ...
3 Biotech Stocks to Buy Now: May 2024
InvestorPlace· 1 day agoWhile there could be several reasons for this, such as the COVID-19 pandemic bringing the value of biotechnology to the forefront or even the expansion...
The Petri Dish: Dyne’s public offering, Kronos’ new CFO - Boston Business Journal
The Business Journals· 3 hours agoCheck out the latest from local companies Dyne Therapeutics, Kronos Bio and Portal Biotechnologies...
Cytokinetics secures up to $575M in royalty deal, frustrating investors
BioPharma Dive via Yahoo Finance· 9 hours agoThe biotech’s decision to give Royalty Pharma a greater share of future drug sales suggests a lower...
